Covalab, a biotechnology company specializing in the development and production of recombinant proteins and antibodies for diagnostics and therapeutics, has been awarded €491,152 in funding for its BioDiaThera project. The…
Covalab, a biotechnology company specializing in the development and production of recombinant proteins and antibodies for diagnostics and therapeutics, has been awarded €491,152 in funding for its BioDiaThera project. The…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference